Related Experiment Video
Updated: Jul 30, 2025

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Long-term outcomes after coronary artery bypass graft with or without surgical ventricular reconstruction in patients
Tao Yang1, Xin Yuan1, Baotong Li1
1Department of Cardiovascular Surgery, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Cardiovascular Diseases, Beijing, China.
Insights
Coronary artery bypass graft (CABG) with surgical ventricular reconstruction (SVR) improves long-term outcomes for patients with chronic myocardial infarction (MI) and severe left ventricular (LV) dysfunction. This approach reduces heart failure rehospitalizations and enhances cardiovascular event-free survival compared to isolated CABG.
Area of Science:
- Cardiology
- Cardiac Surgery
- Cardiovascular Imaging
Background:
- Patients with chronic myocardial infarction (MI) and severe left ventricular (LV) dysfunction face poor clinical outcomes.
- Surgical ventricular reconstruction (SVR) is a potential treatment to improve LV function post-MI.
- The efficacy of SVR combined with coronary artery bypass graft (CABG) versus isolated CABG (I-CABG) requires further investigation.
Purpose of the Study:
- To compare the long-term outcomes of CABG with SVR versus I-CABG in patients with chronic MI and severe LV dysfunction.
- To evaluate the impact of CABG+SVR on cardiovascular events and survival rates.
- To assess the influence of SVR on rehospitalization rates for congestive heart failure (CHF).
Main Methods:
- A prospective study involving 140 patients with chronic MI and severe LV dysfunction.
- Patients underwent contrast-enhanced cardiovascular magnetic resonance imaging (CE-CMR) pre-operatively.
- Comparison of outcomes between 70 patients who received CABG+SVR and 70 patients who received I-CABG.
Main Results:
- No significant differences in baseline characteristics, LV function, or late gadolinium enhancement (LGE) between groups.
- CABG+SVR group had longer cardiopulmonary bypass and ventilation times.
- Mean follow-up of 123.1 months revealed fewer CHF rehospitalizations (4.3% vs. 19.1%) and higher cumulative cardiovascular event-free survival (87.0% vs. 67.6%) in the CABG+SVR group.
- No significant difference in mortality rates was observed (2.9% vs. 4.4%).
Conclusions:
- CABG+SVR and I-CABG demonstrate similar perioperative outcomes in this patient cohort.
- CABG+SVR significantly reduces rehospitalizations for CHF and improves cumulative cardiovascular event-free survival.
- SVR in conjunction with CABG offers significant long-term benefits for selected patients with chronic MI and severe LV dysfunction.
Background:
Patients with chronic myocardial infarction (MI) and severe left ventricular (LV) dysfunction have poor clinical outcomes. This study aimed to determine whether coronary artery bypass graft (CABG) with surgical ventricular reconstruction (SVR) leads to further improvement in long-term patient outcomes compared with isolated CABG (I-CABG).
Methods:
From April 2010 to June 2013, 140 consecutive patients with chronic MI and severe LV dysfunction who received contrast-enhanced cardiovascular magnetic resonance imaging (CE-CMR) within 1 month before surgery were enrolled in this study. The cardiovascular events (CVEs) and long-term survival of patients who underwent CABG and SVR were compared with those who met the criteria for SVR but received I-CABG.
Results:
A total of 140 patients were included in the final analysis, including 70 patients who underwent CABG and SVR and 70 patients who underwent I-CABG. No differences were observed in the baseline characteristics, LV function, and late gadolinium enhancement (LGE) between the two groups. CABG+SVR patients experienced a longer cardiopulmonary bypass (CPB) time (116.0±35.0 vs. 100.2±23.8 minutes, P=0.002) and ventilation time [median (interquartile range): 22.0 (17.0, 37.0) vs. 20.0 (15.0, 24.0) hours, P=0.019] than I-CABG patients. During a mean follow-up of 123.1±12.7 months (range, 102-140 months), the CABG+SVR group had fewer rehospitalizations for congestive heart failure (CHF) (4.3% vs. 19.1%, P=0.007), but no statistical difference in the mortality rate was observed (2.9% vs. 4.4%, P=0.987). The cumulative CVE-free survival rate was significantly higher in CABG+SVR patients (87.0% vs. 67.6%, P=0.007).
Conclusions:
Our findings indicated that patients with chronic MI and severe LV dysfunction experienced similar perioperative outcomes after CABG+SVR or I-CABG. However, the CABG+SVR group resulted in fewer rehospitalizations for CHF and a higher cumulative CVE-free survival rate.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
Aortic Regurgitation III: Medical Management

